Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Total Liabilities: 2019-2023

Historic Total Liabilities for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $521.1 million.

  • ADC Therapeutics' Total Liabilities rose 22.04% to $521.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.9 billion, marking a year-over-year increase of 11.28%. This contributed to the annual value of $411.4 million for FY2022, which is 8.96% down from last year.
  • According to the latest figures from Q3 2023, ADC Therapeutics' Total Liabilities is $521.1 million, which was up 1.01% from $515.9 million recorded in Q2 2023.
  • ADC Therapeutics' 5-year Total Liabilities high stood at $521.1 million for Q3 2023, and its period low was $145,467 during Q3 2020.
  • Over the past 3 years, ADC Therapeutics' median Total Liabilities value was $427.0 million (recorded in 2022), while the average stood at $401.5 million.
  • As far as peak fluctuations go, ADC Therapeutics' Total Liabilities skyrocketed by 309,709.79% in 2021, and later dropped by 8.96% in 2022.
  • Over the past 5 years, ADC Therapeutics' Total Liabilities (Quarterly) stood at $26.5 million in 2019, then reached $145,467 in 2020, then soared by 309,709.79% to $451.9 million in 2021, then declined by 8.96% to $411.4 million in 2022, then rose by 22.04% to $521.1 million in 2023.
  • Its Total Liabilities stands at $521.1 million for Q3 2023, versus $515.9 million for Q2 2023 and $430.0 million for Q1 2023.